lincomycin NDC 70436-035

NDC codes

FDA NDC Directory

Product NDC (as listed)70436-035Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70436-0035Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70436-035-80	70436003580	1 VIAL in 1 CARTON (70436-035-80) / 10 mL in 1 VIALMarketed from Feb 23, 2023
70436-035-82	70436003582	10 VIAL in 1 CARTON (70436-035-82) / 10 mL in 1 VIALMarketed from Feb 23, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): lincomycin
Generic name (nonproprietary): lincomycin
Active ingredients: Lincomycin — 300 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous
Labeler: Slate Run Pharmaceuticals, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216662
Marketing start: Feb 23, 2023
Listing expires: Dec 31, 2026
Identifiers: Product ID 70436-035_f79cdb51-41ca-2bb3-e053-6294a90abb15SPL ID f79cdb51-41ca-2bb3-e053-6294a90abb15SPL set ID 7efe038a-8d67-4151-864a-b4863b46643eRxCUI 239212UNII BOD072YW0F

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470436003580 followed by a unit qualifier and the quantity

Package 70436-0035-80. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 22, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Lincomycin Injection sterile solution is indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of CDAD, as described in the BOXED WARNING , before selecting lincomycin the physician should consider the nature of the infection and the suitability of other alternatives. Indicated surgical procedures should be performed in conjunction with antibacterial therapy. Lincomycin Injection may be administered concomitantly with other antimi…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216662

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216662
Product	Strength	Form · route	Labeler	Product NDC
lincomycin	Lincomycin 300 mg/mL	Injection, SolutionIntramuscular, Intravenous	Slate Run Pharmaceuticals, LLC	70436-034